Free Trial
NASDAQ:TVRD

Tvardi Therapeutics (TVRD) Stock Price, News & Analysis

Tvardi Therapeutics logo
$24.00 +0.21 (+0.88%)
As of 08/15/2025 04:00 PM Eastern

About Tvardi Therapeutics Stock (NASDAQ:TVRD)

Key Stats

Today's Range
$23.79
$24.62
50-Day Range
$21.45
$29.83
52-Week Range
$8.13
$34.31
Volume
12,588 shs
Average Volume
26,996 shs
Market Capitalization
$224.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$64.25
Consensus Rating
Buy

Company Overview

Receive TVRD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tvardi Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

TVRD Stock News Headlines

Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
See More Headlines

TVRD Stock Analysis - Frequently Asked Questions

Tvardi Therapeutics' stock was trading at $29.09 at the start of the year. Since then, TVRD shares have decreased by 17.5% and is now trading at $24.00.

Tvardi Therapeutics, Inc. (NASDAQ:TVRD) posted its earnings results on Thursday, August, 14th. The company reported ($1.00) EPS for the quarter, missing analysts' consensus estimates of ($0.51) by $0.49. Tvardi Therapeutics had a negative net margin of 595.39% and a negative trailing twelve-month return on equity of 710.04%.

Tvardi Therapeutics' top institutional investors include Slate Path Capital LP (7.52%), 683 Capital Management LLC (1.88%), Geode Capital Management LLC (1.20%) and Marshall Wace LLP (0.27%).

Shares of TVRD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/14/2025
Today
8/17/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:TVRD
Previous Symbol
NASDAQ:TVRD
CIK
1346830
Web
N/A
Employees
80
Year Founded
N/A

Price Target and Rating

High Price Target
$78.00
Low Price Target
$52.00
Potential Upside/Downside
+167.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$70.87 million
Net Margins
-595.39%
Pretax Margin
-600.65%
Return on Equity
-710.04%
Return on Assets
-37.18%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
32.48
Quick Ratio
31.73

Sales & Book Value

Annual Sales
$7.14 million
Price / Sales
31.46
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($3.02) per share
Price / Book
-7.95

Miscellaneous

Outstanding Shares
9,360,000
Free Float
9,071,000
Market Cap
$224.64 million
Optionable
N/A
Beta
0.21
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:TVRD) was last updated on 8/17/2025 by MarketBeat.com Staff
From Our Partners